Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study
Crossref DOI link: https://doi.org/10.1007/s12032-014-0074-9
Published Online: 2014-06-24
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mutlu, Hasan
Gündüz, Şeyda
Karaca, Halit
Büyükçelik, Abdullah
Cihan, Yasemin Benderli
Erden, Abdülsamet
Akca, Zeki
Coşkun, Hasan Şenol
Text and Data Mining valid from 2014-06-24